135 related articles for article (PubMed ID: 12790078)
1. [Chronic lymphoproliferative syndromes in Chile. A prospective study in 132 patients].
Cabrera ME; Marinov N; Guerra C; Morilla R; Matutes E
Rev Med Chil; 2003 Mar; 131(3):291-8. PubMed ID: 12790078
[TBL] [Abstract][Full Text] [Related]
2. [Adult T cell leukemia lymphoma in Chile. A clinical pathologic and molecular study of 26 patients].
Cabrera ME; Labra S; Meneses P; Matutes E; Cartier L; Ford AM; Greaves MF
Rev Med Chil; 1999 Aug; 127(8):935-44. PubMed ID: 10752254
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
4. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of hepatitis B and C virus, HTLV-1 and HIV in type B lymphoproliferative syndromes in Gabon].
Perret JL; Moussavou-Kombila JB; Delaporte E; Minko-Mi-Etoua D; Pemba LF; Boguikouma JB; Nzenze JR; Deparis X; Larouzé B
Bull Soc Pathol Exot; 2003 Nov; 96(4):275-8. PubMed ID: 14717040
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic study of lymphoproliferative diseases].
Cabrera ME; Majlis A; Labra S; Carrasco AM
Rev Med Chil; 1992 Jul; 120(7):772-7. PubMed ID: 1341818
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 and associated adult T-cell leukemia/lymphoma.
Mahieux R; Gessain A
Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
10. Human T-cell lymphotropic virus type 1 (HTLV-1) and lymphoid malignancies in Dominica: a seroprevalence study.
Adedayo OA; Shehu SM
Am J Hematol; 2004 Dec; 77(4):336-9. PubMed ID: 15551358
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphoproliferative disorders.
Catovsky D
Curr Opin Oncol; 1995 Jan; 7(1):3-11. PubMed ID: 7696361
[TBL] [Abstract][Full Text] [Related]
12. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
Amano M; Kurokawa M; Ogata K; Itoh H; Kataoka H; Setoyama M
J Dermatol; 2008 May; 35(5):270-5. PubMed ID: 18477226
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
[TBL] [Abstract][Full Text] [Related]
14. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ
Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126
[TBL] [Abstract][Full Text] [Related]
15. [The secretion of monoclonal immunoglobulins in chronic lymphoproliferative diseases].
Sinitsina TV; Andreeva NE; Abelev GI
Ter Arkh; 1988; 60(5):50-3. PubMed ID: 3175928
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
17. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].
Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J
Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727
[TBL] [Abstract][Full Text] [Related]
18. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
20. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
